Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

Université de Montréal

$150,000.00

Clinical, echocardiographic and magnetic resonance evaluation of the pulmonary autograft.

EF 2020-21

Résumé
Aortic stenosis, a valve disease which limits the ability of the heart to pump blood to the rest of the body, is the most common valve disease in Europe and North America. Left untreated, this condition is associated with a mortality of >50% at 3 years following the onset of symptoms. Aortic valve replacement (AVR) has improved the natural history of patients suffering from this disease. Current surgical options all have advantages and drawbacks. Mechanical prostheses are durable but require lifelong anticoagulation with an associated risk of bleeding and stroke. Biologic prostheses do not require anticoagulation but have an increased risk of failure. More importantly, both prostheses are associated with suboptimal long-term survival. In patients <65 at the time of surgery, survival is reduced by more than 10 years compared with the general population. A third option, known as the Ross procedure puts a living valve in the aortic position. The Ross procedure consists of replacing the aortic valve with the patient's own pulmonary valve (pulmonary autograft). A valve from a deceased donor is used to replace the pulmonary valve. The Ross procedure is associated with better survival. However, it is a more complex operation. To date, no study has adequately compared the outcomes patients undergoing prosthetic AVR or a Ross procedure. Patients <65 years old represent 25% of all patients requiring AVR. It is thus pressing to determine which valve substitute offers them the best long-term outcomes. We hypothesize that the characteristics of the pulmonary autograft result in lower heart workload, which leads to better long-term survival. To test this hypothesis, we will use imaging studies to assess the heart workload at rest and during exercise in patients who have received a mechanical prosthesis, a pulmonary autograft and in healthy volunteers. We will also assess the clinical outcomes (ex: survival) of patients undergoing a mechanical AVR and a Ross procedure.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
437286
Name
Chauvette Vincent
Region
Qu&eacute;bec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Clinical, echocardiographic and magnetic resonance evaluation of the pulmonary autograft.
Programtype2
Studentship Programs
Orgnameinp2
Universit&eacute; de Montr&eacute;al
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Aortic Valve Replacement; Cardiac Imaging; Cardiac Valves; Pulmonary Autograft; Valvulo-Arterial Impendance
Abstract
Aortic stenosis, a valve disease which limits the ability of the heart to pump blood to the rest of the body, is the most common valve disease in Europe and North America. Left untreated, this condition is associated with a mortality of >50% at 3 years following the onset of symptoms. Aortic valve replacement (AVR) has improved the natural history of patients suffering from this disease. Current surgical options all have advantages and drawbacks. Mechanical prostheses are durable but require lifelong anticoagulation with an associated risk of bleeding and stroke. Biologic prostheses do not require anticoagulation but have an increased risk of failure. More importantly, both prostheses are associated with suboptimal long-term survival. In patients <65 at the time of surgery, survival is reduced by more than 10 years compared with the general population. A third option, known as the Ross procedure puts a living valve in the aortic position. The Ross procedure consists of replacing the aortic valve with the patient's own pulmonary valve (pulmonary autograft). A valve from a deceased donor is used to replace the pulmonary valve. The Ross procedure is associated with better survival. However, it is a more complex operation. To date, no study has adequately compared the outcomes patients undergoing prosthetic AVR or a Ross procedure. Patients <65 years old represent 25% of all patients requiring AVR. It is thus pressing to determine which valve substitute offers them the best long-term outcomes. We hypothesize that the characteristics of the pulmonary autograft result in lower heart workload, which leads to better long-term survival. To test this hypothesis, we will use imaging studies to assess the heart workload at rest and during exercise in patients who have received a mechanical prosthesis, a pulmonary autograft and in healthy volunteers. We will also assess the clinical outcomes (ex: survival) of patients undergoing a mechanical AVR and a Ross procedure.
Competitiondate
202011
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Chauvette, Vincent
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~